Oppenheimer & Co. Inc. Sells 9,260 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Oppenheimer & Co. Inc. lessened its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 36.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,207 shares of the company’s stock after selling 9,260 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in GE HealthCare Technologies were worth $1,473,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Capital Research Global Investors lifted its holdings in shares of GE HealthCare Technologies by 2.8% during the fourth quarter. Capital Research Global Investors now owns 51,344,719 shares of the company’s stock valued at $3,969,975,000 after acquiring an additional 1,401,566 shares during the period. Hotchkis & Wiley Capital Management LLC grew its holdings in shares of GE HealthCare Technologies by 9.4% during the fourth quarter. Hotchkis & Wiley Capital Management LLC now owns 5,511,973 shares of the company’s stock worth $426,186,000 after purchasing an additional 471,910 shares during the last quarter. Dimensional Fund Advisors LP increased its position in GE HealthCare Technologies by 17.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,454,690 shares of the company’s stock valued at $267,121,000 after acquiring an additional 504,287 shares in the last quarter. Norges Bank bought a new position in shares of GE HealthCare Technologies in the fourth quarter worth about $229,052,000. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of GE HealthCare Technologies by 2.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,910,148 shares of the company’s stock valued at $147,693,000 after purchasing an additional 42,868 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

Table of Contents

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $80.28 on Monday. The stock has a market capitalization of $36.64 billion, a price-to-earnings ratio of 23.47, a PEG ratio of 2.89 and a beta of 1.20. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50. The firm has a fifty day simple moving average of $78.78 and a 200 day simple moving average of $81.93. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.11.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, meeting the consensus estimate of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The company had revenue of $4.65 billion during the quarter, compared to analysts’ expectations of $4.80 billion. During the same quarter last year, the company earned $0.85 EPS. GE HealthCare Technologies’s revenue for the quarter was down 1.2% compared to the same quarter last year. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.27 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be issued a $0.03 dividend. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. The ex-dividend date of this dividend is Friday, July 19th. GE HealthCare Technologies’s payout ratio is presently 3.51%.

Wall Street Analyst Weigh In

Several research firms have recently commented on GEHC. The Goldman Sachs Group assumed coverage on GE HealthCare Technologies in a research note on Thursday, May 30th. They issued a “neutral” rating and a $87.00 target price for the company. Evercore ISI raised their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. Bank of America cut their target price on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. Mizuho lowered their price target on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research note on Wednesday, May 1st. Finally, Citigroup lifted their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Five equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $94.09.

Get Our Latest Analysis on GE HealthCare Technologies

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Jan Makela sold 20,227 shares of the company’s stock in a transaction on Monday, May 13th. The shares were sold at an average price of $81.57, for a total transaction of $1,649,916.39. Following the sale, the chief executive officer now directly owns 63,348 shares of the company’s stock, valued at $5,167,296.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other GE HealthCare Technologies news, CEO Jan Makela sold 20,227 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $81.57, for a total value of $1,649,916.39. Following the sale, the chief executive officer now owns 63,348 shares in the company, valued at $5,167,296.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Frank R. Jimenez bought 1,315 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, May 1st. The shares were acquired at an average price of $76.52 per share, with a total value of $100,623.80. Following the completion of the purchase, the insider now directly owns 75,796 shares in the company, valued at approximately $5,799,909.92. The disclosure for this purchase can be found here. Over the last three months, insiders sold 90,482 shares of company stock valued at $7,369,137. 0.27% of the stock is owned by corporate insiders.

GE HealthCare Technologies Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.